CTCBIO Inc (060590) - Total Liabilities

Latest as of September 2025: ₩77.43 Billion KRW ≈ $52.47 Million USD

Based on the latest financial reports, CTCBIO Inc (060590) has total liabilities worth ₩77.43 Billion KRW (≈ $52.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CTCBIO Inc (060590) cash conversion ratio to assess how effectively this company generates cash.

CTCBIO Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how CTCBIO Inc's total liabilities have evolved over time, based on quarterly financial data. Check 060590 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

CTCBIO Inc Competitors by Total Liabilities

The table below lists competitors of CTCBIO Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Chemfab Alkalis Limited NSE:CHEMFAB	India	Rs1.88 Billion
Immutep Ltd AU:IMM	Australia	AU$13.35 Million
Fortune Minerals Limited TO:FT	Canada	CA$17.76 Million
Sensus Healthcare Inc NASDAQ:SRTS	USA	$4.94 Million
Lacroix Group SA PA:LACR	France	€341.60 Million
China Fangda Group Co Ltd SHE:200055	China	HK$6.98 Billion
Gmb Korea KO:013870	Korea	₩401.22 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down CTCBIO Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 060590 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.16	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.08	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.52	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CTCBIO Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CTCBIO Inc (2011–2024)

The table below shows the annual total liabilities of CTCBIO Inc from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩84.07 Billion ≈ $56.97 Million	-7.02%
2023-12-31	₩90.42 Billion ≈ $61.27 Million	-1.65%
2022-12-31	₩91.94 Billion ≈ $62.30 Million	+10.48%
2021-12-31	₩83.21 Billion ≈ $56.39 Million	-17.49%
2020-12-31	₩100.86 Billion ≈ $68.35 Million	-9.76%
2019-12-31	₩111.76 Billion ≈ $75.74 Million	+6.62%
2018-12-31	₩104.82 Billion ≈ $71.03 Million	-11.04%
2017-12-31	₩117.82 Billion ≈ $79.84 Million	+20.49%
2016-12-31	₩97.78 Billion ≈ $66.26 Million	+3.50%
2015-12-31	₩94.47 Billion ≈ $64.02 Million	+23.28%
2014-12-31	₩76.63 Billion ≈ $51.93 Million	+31.56%
2013-12-31	₩58.25 Billion ≈ $39.47 Million	-7.49%
2012-12-31	₩62.96 Billion ≈ $42.67 Million	+29.78%
2011-12-31	₩48.52 Billion ≈ $32.88 Million	--

About CTCBIO Inc

KQ:060590 Korea Biotechnology

Market Cap

$63.43 Million

₩93.60 Billion KRW

Market Cap Rank

#20960 Global

#1294 in Korea

Share Price

₩3915.00

Change (1 day)

+0.13%

52-Week Range

₩3620.00 - ₩7450.00

All Time High

₩18000.00